Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 5 Bromo 2 chlorobenzoic acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN105622382B offers high-yield synthesis for Dapagliflozin intermediates with reduced waste and cost efficiency for global supply chains.
Novel synthesis of 5-bromo-2-chlorobenzoic acid from salicylic acid. High purity, cost-effective route for API intermediates. Reliable supply chain partner.
Patent CN113801010A reveals a high-yield route for 5-bromo-2-chlorobenzoic acid, a key SGLT2 inhibitor intermediate, offering superior purity and supply chain stability.
Patent CN110002989B reveals a high-selectivity synthesis for 5-bromo-2-chlorobenzoic acid, offering cost reduction and superior purity for SGLT-2 inhibitor manufacturing.
Novel dibromo-amino silica gel method achieves >99% selectivity and >99.8% purity for SGLT-2 inhibitors, significantly reducing waste and manufacturing costs.
Patent CN118652170A enables high-yield synthesis of Dapagliflozin intermediates with reduced waste and cost for global supply chains.
Patent CN112979448A reveals a green synthesis route for SGLT-2 inhibitor intermediates with >99% purity and recyclable reagents.
Novel salicylic acid route for high-purity pharma intermediate. Cost-effective, scalable, low pollution manufacturing solution for global supply chains.